VNDA vs DBVT โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
VNDA Captures Institutional Edge (3โ1 Pillars ยท 7โ3 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Vanda Pharmaceuticals Inc. (VNDA) driven by superior Valuation, Growth & Margin, Momentum & Technical while DBVT counters with relative strength in Options & Structure. Fundamentally, VNDA trades at 103.1x Forward P/E with -77.6% operating margin (+24.1% YoY revenue) versus DBVT at N/M Forward P/E and -5577.0% operating margin (-42.9% YoY). In options structure, VNDA sits in BREAKDOWN (75th %ile IV; Dealer Gamma Walls on Pro) against DBVT sits in SURGE (13th %ile IV; Dealer Gamma Walls on Pro).
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)
| Period | VNDA Revenue | DBVT Revenue | VNDA Op. Margin | DBVT Op. Margin | Margin Edge |
|---|---|---|---|---|---|
| FY2018 | $190M | N/A | 11.3% | N/A | VNDA |
| FY2019 | $230M | $10M | 10.0% | -1162.8% | VNDA |
| FY2020 | $250M | $10M | 11.0% | -1408.7% | VNDA |
| FY2021 | $270M | $10M | 15.7% | -1727.6% | VNDA |
| FY2022 | $250M | $0M | 2.5% | -1994.9% | VNDA |
| FY2023 | $190M | $20M | -7.2% | -486.0% | VNDA |
| FY2024 | $200M | $0M | -20.5% | -2808.7% | VNDA |
| FY2025 | $220M | $10M | -70.0% | -2609.2% | VNDA |
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | VNDA | DBVT | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $238.9M | $682.5M | Larger Scale | DBVT |
| Trailing P/E Ratio Valuation | 103.1x | N/M | Lower Multiple | VNDA |
| Forward P/E Ratio Valuation | 103.1x | N/M | Lower Multiple | VNDA |
| Revenue Growth (YoY) Growth | +24.1% | -42.9% | Higher Growth | VNDA |
| Operating Margin (TTM) Profitability | -77.6% | -5577.0% | Higher Margin | VNDA |
| Net Profit Margin Profitability | -119.9% | 0.0% | Higher Margin | DBVT |
| Return on Equity (ROE) Capital Efficiency | -82.5% | -205.8% | Higher ROE | VNDA |
| 52-Week Range Position Momentum | 4% ($4โ$10) | 9% ($9โ$26) | Stronger Trend | DBVT |
| Beta / 30D Volatility Risk Regime | 1.25ฮฒ ยท 61% Vol | 1.17ฮฒ ยท 77% Vol | Lower Realized Risk | VNDA |
| Unified Institutional Score Composite Signal | 49.0 / 100 (HOLD) | 30.9 / 100 (SELL) | Higher Composite | VNDA |